Literature DB >> 24497406

Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysis.

Manabu Kinoshita1, Takashi Sasayama, Yoshitaka Narita, Fumio Yamashita, Atsushi Kawaguchi, Yasuyoshi Chiba, Naoki Kagawa, Kazuhiro Tanaka, Eiji Kohmura, Hideyuki Arita, Yoshiko Okita, Makoto Ohno, Yasuji Miyakita, Soichiro Shibui, Naoya Hashimoto, Toshiki Yoshimine.   

Abstract

BACKGROUND: MRI group analysis is a powerful tool for elucidating pathological conditions in the brain that are challenging to reveal from single subject analysis. This research aimed to elucidate special distribution characteristics of primary central nervous system lymphoma (PCNSL) within the brain with respect to molecular marker expression patterns.
METHODS: MR images from 100 treatment-naive PCNSL patients were collected and registered onto averaged standard anatomical MRI (MNI152). Gadolinium-enhanced lesions were extracted, and a lesion frequency map was created. Lymphoma subtypes were classified as germinal center B (GCB) or non-GCB by immunohistochemistry in 90 patients.
RESULTS: A PCNSL frequency map showed that these tumors tended to occur around the lateral, third and fourth ventricles. Moreover, GCB (27 cases) and non-GCB (63 cases) PCNSL frequency maps showed GCB lymphomas located at the upper tegmentum and cerebellum around the fourth ventricle, while non-GCB lymphomas tended to occupy the anterior fornix. These differences were significant and confirmed by the existence of voxels with P values <.05 (random permutation analysis with voxel-wise Fisher' exact test). This is the very first report to address phenotypical and spatial distributional differences between GCB and non-GCB PCNSL using an MR group analytical method.

Entities:  

Keywords:  MRI; germinal center; primary central nervous system lymphoma

Mesh:

Year:  2014        PMID: 24497406      PMCID: PMC3984556          DOI: 10.1093/neuonc/not319

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  15 in total

1.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain.

Authors:  E T Bullmore; J Suckling; S Overmeyer; S Rabe-Hesketh; E Taylor; M J Brammer
Journal:  IEEE Trans Med Imaging       Date:  1999-01       Impact factor: 10.048

2.  Primary intracerebral malignant lymphoma: report of 248 cases.

Authors:  B Bataille; V Delwail; E Menet; P Vandermarcq; P Ingrand; M Wager; G Guy; F Lapierre
Journal:  J Neurosurg       Date:  2000-02       Impact factor: 5.115

3.  A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.

Authors:  Sophie Camilleri-Broët; Emmanuelle Crinière; Philippe Broët; Vincent Delwail; Karima Mokhtari; Anne Moreau; Michèle Kujas; Martine Raphaël; Wafae Iraqi; Catherine Sautès-Fridman; Philippe Colombat; Khê Hoang-Xuan; Antoine Martin
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

Authors:  Jane N Winter; Edie A Weller; Sandra J Horning; Maryla Krajewska; Daina Variakojis; Thomas M Habermann; Richard I Fisher; Paul J Kurtin; William R Macon; Mukesh Chhanabhai; Raymond E Felgar; Eric D Hsi; L Jeffrey Medeiros; James K Weick; John C Reed; Randy D Gascoyne
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

5.  Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template.

Authors:  Jack L Lancaster; Diana Tordesillas-Gutiérrez; Michael Martinez; Felipe Salinas; Alan Evans; Karl Zilles; John C Mazziotta; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2007-11       Impact factor: 5.038

6.  A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.

Authors:  Anamarija M Perry; Teresa M Cardesa-Salzmann; Paul N Meyer; Luis Colomo; Lynette M Smith; Kai Fu; Timothy C Greiner; Jan Delabie; Randy D Gascoyne; Lisa Rimsza; Elaine S Jaffe; German Ott; Andreas Rosenwald; Rita M Braziel; Raymond Tubbs; James R Cook; Louis M Staudt; Joseph M Connors; Laurie H Sehn; Julie M Vose; Armando López-Guillermo; Elias Campo; Wing C Chan; Dennis D Weisenburger
Journal:  Blood       Date:  2012-06-26       Impact factor: 22.113

7.  Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.

Authors:  Hiroyuki Momota; Yoshitaka Narita; Akiko M Maeshima; Yasuji Miyakita; Aya Shinomiya; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  J Neurooncol       Date:  2009-12-13       Impact factor: 4.130

Review 8.  Nasal T-cell lymphoma.

Authors:  L M Weiss; D A Arber; J G Strickler
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

9.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

10.  Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.

Authors:  Ching-Hung Lin; Kuan-Ting Kuo; Shih-Sung Chuang; Sung-Hsin Kuo; Julia Hueimei Chang; Kung-Chao Chang; Hui-Chen Hsu; Hwei-Fang Tien; Ann-Lii Cheng
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

View more
  8 in total

1.  Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor.

Authors:  Koji Takano; Manabu Kinoshita; Masatoshi Takagaki; Mio Sakai; Souichirou Tateishi; Takamune Achiha; Ryuichi Hirayama; Kazumi Nishino; Junji Uchida; Toru Kumagai; Jiro Okami; Atsushi Kawaguchi; Naoya Hashimoto; Katsuyuki Nakanishi; Fumio Imamura; Masahiko Higashiyama; Toshiki Yoshimine
Journal:  Neuro Oncol       Date:  2015-10-31       Impact factor: 12.300

2.  Postcentral gyrus resection of opercular gliomas is a risk factor for motor deficits caused by damaging the radiologically invisible arteries supplying the descending motor pathway.

Authors:  Ichiyo Shibahara; Sumito Sato; Takuichiro Hide; Ryuta Saito; Masayuki Kanamori; Yukihiko Sonoda; Teiji Tominaga; Toshihiro Kumabe
Journal:  Acta Neurochir (Wien)       Date:  2021-02-03       Impact factor: 2.216

3.  The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.

Authors:  Kenichiro Asano; Yoji Yamashita; Takahiro Ono; Manabu Natsumeda; Takaaki Beppu; Kenichiro Matsuda; Masahiro Ichikawa; Masayuki Kanamori; Masashi Matsuzaka; Akira Kurose; Kiyoshi Saito; Yukihiko Sonoda; Kuniaki Ogasawara; Yukihiko Fujii; Hiroaki Shimizu; Hiroki Ohkuma; Chifumi Kitanaka; Takamasa Kayama; Teiji Tominaga
Journal:  Int J Clin Oncol       Date:  2021-10-12       Impact factor: 3.402

4.  Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.

Authors:  Danhui Li; Shengjie Li; Zuguang Xia; Jiazhen Cao; Jinsen Zhang; Bobin Chen; Xin Zhang; Wei Zhu; Jianchen Fang; Qiang Liu; Wei Hua
Journal:  EPMA J       Date:  2022-07-15       Impact factor: 8.836

5.  Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?-A Feasibility Study.

Authors:  Marwa Ismail; Virginia Hill; Volodymyr Statsevych; Evan Mason; Ramon Correa; Prateek Prasanna; Gagandeep Singh; Kaustav Bera; Rajat Thawani; Manmeet Ahluwalia; Anant Madabhushi; Pallavi Tiwari
Journal:  Front Comput Neurosci       Date:  2020-12-14       Impact factor: 2.380

6.  Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases.

Authors:  Nobuyuki Izutsu; Manabu Kinoshita; Tomohiko Ozaki; Mio Sakai; Katsuyuki Nakanishi; Takahiro Nakayama; Yasuhiro Tamaki; Haruhiko Kishima
Journal:  Mol Clin Oncol       Date:  2021-06-30

7.  Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.

Authors:  Hideyuki Arita; Manabu Kinoshita; Atsushi Kawaguchi; Masamichi Takahashi; Yoshitaka Narita; Yuzo Terakawa; Naohiro Tsuyuguchi; Yoshiko Okita; Masahiro Nonaka; Shusuke Moriuchi; Masatoshi Takagaki; Yasunori Fujimoto; Junya Fukai; Shuichi Izumoto; Kenichi Ishibashi; Yoshikazu Nakajima; Tomoko Shofuda; Daisuke Kanematsu; Ema Yoshioka; Yoshinori Kodama; Masayuki Mano; Kanji Mori; Koichi Ichimura; Yonehiro Kanemura
Journal:  Sci Rep       Date:  2018-08-06       Impact factor: 4.379

8.  Relationship between normalized distributional pattern and functional outcome in patients with acute cardiogenic cerebral embolism.

Authors:  Masatoshi Takagaki; Manabu Kinoshita; Atsushi Kawaguchi; Akira Murasawa; Kazutami Nakao; Hajime Nakamura; Haruhiko Kishima
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.